[QUOTE="jepjep";29132510]Ja tässä tarkemmin Lancetin asiaa Japanista:
The Japanese Ministry of Health, Labour, and Welfare (MHLW) partially suspended the human papillomavirus (HPV) vaccination programme in June, 2013. Although HPV vaccination has just been included in the routine vaccination schedule and publicly funded since April 2013, a new MHLW directive advises prefectural governors not to actively recommend the vaccine, and to cease all vaccine promotion. However, health facilities are to continue to offer parents seeking the vaccine full support, and facilitate vaccine access. Such advice obviously creates enormous confusion for public health officials, doctors, and parents. A joint meeting of the Vaccine Adverse Reactions Review Committee (VARRC) has indicated that they might remove HPV vaccination from the schedule, despite evidence of its cost-effectiveness in Japan.1
This directive was issued due to fears of adverse events, especially complex regional pain syndrome. However, the present system of reporting adverse events does not follow a systematic process for identifying causality; a rigorous scientific approach is needed to investigate adverse events associated with HPV vaccines.2 Furthermore, the decision to suspend the vaccination programme was taken by a 3:2 vote of the VARRC, without presentation of adequate scientific evidence. Japan's vaccination system suffers from a failure of governancealso reflected in other aspects of the vaccination schedule. Mumps, adult pneumococcal, rotavirus, and hepatitis B vaccines have yet to be introduced in the routine schedule, even though they are recommended by WHO; and other vaccinations (such as Haemophilus influenzae type b and pneumococcal conjugate vaccination) have been introduced without proper cost-effectiveness assessment.
In view of these past failings and the present confusion about HPV vaccination, reform of the Japanese vaccination system is essential. Decisions should be made by an independent advisory committee, such as the Advisory Committee on Immunization Practices in the USA, rather than a committee organised by government bureaucrats, and should be on the basis of verifiable scientific evidence.
Japan is currently experiencing an unusual epidemic of rubella,3 with more than 10 000 cases reported and an increasing number of congenital rubella syndrome cases, which could have been prevented by a well run vaccination programme or an emergent mass vaccination campaign. It is time for Japan to improve the governance and systems for its vaccination programme, to ensure that decisions about vaccination strategy are independent, transparent, and scientific, prevent the resurgence of vaccine preventable diseases, and prevent the confusion the recent suspension decision has caused.[/QUOTE]
Elikkäs lyhyesti Japani ottaa suosituksen rokottaa pois siihen asti että rokotteen turvallisuus voidaan hyväksyä/hylätä. MOLEMMAT vaihtoehdot mahdollisia.
Tahdotaako Suomessa katsoa Japanin tulokset ENNENKUIN lapsia aletaan rokottaan vai tehdäänkö kuten sikainfluenssa rokotteen kanssa eli osa sairastuu,mutta siitä ei välitetä?
Tuleekohan meidän lähdekriittinen nyt kertomaan että Magneetti media ja Lancet ovat samanarvoisia tiedon lähteitä?